IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Accent Microcell IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Chemical sector. Corporate Capital Ventures Private is the merchant banker of Accent Microcell IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 31st October 2023.
Accent Microcell IPO posted revenues of Rs 239.72 crores and PAT of Rs 28.24 crores in FY24 on annualised basis.Financial results of Accent Microcell IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Accent Microcell IPO PAT Margin is 12.01%, ROCE (Return on Capital Employed) is 12.03% as per latest financial. The below table shows Accent Microcell IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Accent Microcell IPO is Rs 294.60 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Accent Microcell IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Accent Microcell IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Accent Microcell IPO is ₹294.60 Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Accent Microcell IPO has a Price-to-Earnings (PE) ratio of 10.44 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Accent Microcell IPO reported revenue of ₹239.72 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Accent Microcell IPO provide insights into sales growth, market demand, and business scalability.
Accent Microcell recorded an EBITDA of ₹ 39.32 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Accent Microcell Profit After Tax (PAT) is ₹28.24 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 235.20 Cr.
EBITDA Margin:
16.72
%
Net Worth: ₹ 51.25 Cr.
Market Capitalisation:
₹ 294.60 Cr.
P/E:
10.44 times
P/BV: 2.27 times
EV/EBITDA: 7.98 times
Accent Microcell operates in Chemical and Manufacturers Of Microcrystalline Cellulose (MCC). The Issue is listed on NSE EMERGE in Dec, 2023. Accent Microcell IPO size was 78.40 with Issue price of 140.00 .
Merchant Banker(s) of Accent Microcell IPO: Corporate Capital Ventures Private Limited
Accent Microcell IPO subscription was 362.41 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Accent Microcell IPO listed at a listing price of 315.00 against the offer price of 140.00.
The current market price of Accent Microcell is 209.75.
Why Us?
